| tüüp : |
ajaleht |
| interneti link : |
https://doi.org/10.1016/0378-5173(90)90008-R |
|
| uurimisrühmad : |
Gand - laboratory of Pharmaceutical technology, State University of Gent |
| Autor : |
De Vroe C, De Muynck C, Remon JP, Samsom M. |
| pealkiri : |
A study on the stability of three antineoplastic drugs and on their sorption by IV delivery systems and end-line filters. |
| publikatsioon : |
Int J Pharm ; 65: 49-56. 1990 |
|
| Tõendite tase : |
|
| füüsikaline stabiilsus : |
|
| Keemiline püsivus : |
|
| Muud meetodid : |
|
| Kommentaarid : |
| Stabiilsuse näitamise võime ebaadekvaatselt hinnatud | | Visuaalne kontroll puudub | | Laguproduktide kohta info puudub |
|
ingredientide nimekiri
 Epirubicin hydrochloride
|
 |
 |
 |
 |
0,05 mg/ml |
4°C |
 |
| 25 |
 |
|
|
|
|
 |
0,05 mg/ml |
4°C |
|
| 30 |
|
|
|
|
 |
|
0,05 mg/ml |
4°C |
|
| 25 |
|
|
|
|
|
|
0,05 mg/ml |
4°C |
|
| 30 |
|
|
|
|
 |
|
0,05 mg/ml |
4°C |
|
| 25 |
|
|
|
|
|
|
0,05 mg/ml |
4°C |
|
| 30 |
|
|
|
|
|
Nimustine
|
|
|
|
 |
2 mg/ml |
25°C |
|
| 7 |
 |
|
|
|
|
|
2 mg/ml |
4°C |
|
| 6 |
|
|
|
|
|
|
2 mg/ml |
25°C |
 |
| 5 |
|
|
|
|
|
|
2 mg/ml |
25°C |
|
| 7 |
|
|
|
|
|
|
2 mg/ml |
4°C |
|
| 6 |
|
|
|
|
|
|
2 mg/ml |
4°C |
|
| 6 |
|
|
|
|
|
| |
+
|
|
|
|
|
| |
+
|
|
|
|
